If Orexigen wins FDA approval for its new weight loss drug, how will it and its pharma partner Takeda take on the obesity market? After all, it's an area where two recent debuts are struggling for recognition. Report
| Wednesday, January 28, 2015 | 11am ET / 8am PT | Sponsored by: Catalent
BASF SE expert Andreas Gryczke will present fundamental understanding of Role of Polymers using hot melt extrusion technology and Catalent's expert Dr. Sampada B Upadhye will present unique approach to formulation development and strategy for scale-up. Learn How BASF & Catalent can Expedite and Resolve your Challenges with development and manufacturing.
FiercePharma is the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Join 150,000+ pharma industry leaders who get FiercePharma via daily email. Click here to get your free weekly email briefing today!